FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Office of Generic Drugs
Chemistry and Bioequivalence Review Teams

Division of Chemistry I Teams

Chemistry 1 Major Therapeutic Class Project Manager Bioequivalence Bioequivalence
Project Manager
Team 1 Antihypertensives
ACE Inhibitors
Angeotensin II Receptor Antagonists
Vasodilators-Prostiglandins
Radiopharmaceutics
Radiopaques
Non-Steriodal Anti-Inflammatories (NSAIDS)
Dat Doan

240-270-8573

FAX 240-276-8504

Divison 1
Team 4
Beth Fritsch

240-276-8782
Team 2

Oncology Agents
Neoplastic Hormonal Agents
Immunomodulators
Inhalation Corticosteriods
Respiratory Agents
Antiasthmatic Agents
Decongestant Agents
Expectorants/antitussives

Esther Chuh

240-276-8530

FAX 240-276-8504

Divison 1
Team 8
Beth Fritsch

240-276-8782
Team 3 Dermatologics
Otics
Ophthalmics
Antifungal Agents-topicals
Anti-Infectives-Quinolones
Retinoid Products
Rosalyn Adigun

240-276-8518

FAX 240-276-8504

Division 1
Team 6
Nam (Esther)
Chun

240-276-8782
Team 5 Diuretics
Sedatives-Hypnotics
Antifungals-systemics
Estrogens
Anti-Infectives
Antiprotozoals
Obsessive/Compulsive Agents Corticosteriods
Benign Prostate Disease Agents
Benjamin Danso

240-276-8527

FAX 240-276-8504

Division 1
Team 6
Nam (Esther)
Chun

240-276-8782

Division of Chemistry II Teams

Chemistry II Major Therapeutic Class Project Manager Bioequivalence Bioequivalence
Project Manager
Team 7 Anti-Ulcer
Antimotility/Antispasmodics
Anticholinergics
Anorexics
CNS Agents
Bipolar Disorders
Fibrinolytics/Thromboembolics
GI Diagnostics
Anti-Parkinson Agents
Theresa Liu

240-276-8555

FAX 240-276-8582

Division 2
Team 7
Christina Thompson

240-276-8782
Team 8 Beta Blockers
Calcium Channel Blockers
Anti-Arrhythmics
Drug Abuse Agents
Vasodilators
Glycosides
Nitin Patel

240-276-8548

FAX 240-276-8582

Division 2
Team 1
Keri Suh

240-276-8782

Team 9 Antivirals
Non-narcotic Analgesics
Narcotic Analgesics
Narcotic Antagonists/Agonists
Migraine Agents
Antifungal Agents - systemic
Laura Longstaff

240-276-8548

FAX 240-276-8582

Division 2
Team 5
Christina Thompson

240-276-8782
Team 10 Antidepressants
Attention Deficit-Hyperactivity Disorder Agents
Nicotine/Anti-nicotine Agents
Coagulants/Anticoagulants
Tom Hinchliffe

240-276-8536

FAX 240-276-8582

Division 2
Team 3
Keri Suh

240-276-8782

 

Division of Chemistry III Teams

Chemistry III Major Therapeutic Class Project Manager Bioequivalence Bioequivalence
Project Manager
Team 4 Antipsychotics
Vitamins
Antihistamines-Cough Preps
Muscle Relaxants
Oral Contraceptive Agents
Androgens/Anabolic Steroids
Dental Products
Leigh Ann Bradford

240-276-8453

FAX 240-276-8474

Division 1
Team 2
Steven Mazzella

240-276-8782

Team 6 Antibiotics
Antifungals*
Antineoplastic Antibiotics*
Immuno-Suppressants*

*Fermentation derived

Roberta Szydlo

240-276-8476

FAX 240-276-8474

Division 2
Teams 3 and 7
Keri Suh
or
Christina Thompson

240-276-8782

Team 11 Alzheimers Agents
Anticonvulsants
Antituberculosis Agents
Ophthalmic Antibiotics
Hyper/Hypoglycemics
Sexual Dysfunction Agents
Lisa Kwok

240-276-8494

FAX 240-276-8474

Division 2
Teams 1 and 5
Keri Suh
or
Christina Thompson

240-276-8782

 

Team 12 Anti-Anxiety Agents
Anti-Alcoholism
Potassium Salts
Cholesterol lowering Agents
Surgical Agents
Anesthesia Agents
Anti-malarial Agents
Large Volume Parenterals
Nutrients/Amino Acids
Jeanne Skanchy

240-276-8467

FAX 240-276-8474

Division 1
Teams 6 and 8
Nam (Esther)
Chun
or
Beth Fritsch

240-276-8782

to top arrow Back to Top     back arrow Back to Office of Generic Drugs

Date updated: September 8, 2008

horizonal rule